Facebook User Plaintiffs and Defendant Facebook have agreed to resolve In re: Facebook, Inc. Consumer Privacy User Profile Litig., No. 3:18-md-02843-VC, the class action arising out of the Cambridge Analytica scandal, for $725 million—the largest settlement ever of a privacy class action in the United States.

Keller Rohrback is honored to have been recognized by the American Antitrust Institute (AAI) for its work on the In re EpiPen Marketing, Sales Practices, and Antitrust Litigation.  The Keller Rohrback team of Lynn Sarko, Gretchen Freeman Cappio, Alison Chase and Felicia Craick will be recognized, alongside co-counsel from Burn Charest LLP, Robbins Geller Rudman & Dowd LLP, Pritzker Levine LLP, Sharp Law LLP, Boies Schiller Flexner LLP, on November 9th at the 2022 AAI Awards Night in the category of Outstanding Antitrust Litigation Achievement in Private Law Practice.

Keller Rohrback is pleased to have been recognized for its antitrust work in the 2021 Antitrust Annual Report published in partnership by the Center for Litigation and Courts at UC Hastings College of Law and The Huntington National Bank.  Keller Rohrback was included in their rankings for the category of “Top 50 Cases with Settlements Reaching Final Approval 2009-2021.” Keller Rohrback achieved this ranking by having been a part of one of the largest antitrust settlements reached during this time period.  Congratulations to the Keller Rohrback Antitrust Team!

On April 19, 2022, Judge Harry D. Leinenweber of the Northern District of Illinois appointed Keller Rohrback as Interim Co-Lead Counsel.  Keller Rohrback attorneys Dean Kawamoto, Derek Loeser, Gretchen Freeman Cappio, and Felicia Craick are proud to represent the proposed class of Illinois citizens who have claims under BIPA based on Amazon’s collecting and using their biometric data through the Amazon Photo service.

EpiPen Settlement Update

In re EpiPen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation
United States District Court, District of Kansas
MDL No. 2785

Drug manufacturer Johnson & Johnson and three major drug distributors: Cardinal Health Inc., McKesson Corp. and AmerisourceBergen Corp., have announced that they will collectively pay $26 billion to settle thousands of lawsuits nationwide stemming from claims that they helped fuel the tragic U.S. Opioid epidemic.

If you have been a victim of false advertising claims stating that a product can prevent, treat, mitigate, diagnose, or cure COVID-19, Keller Rohrback wants to hear your story. Please contact our consumer protection team at covid19support@kellerrohrback.com or (800) 776-6044 for a consultation at no cost to you.

According to the National Highway Traffic Safety Administration (NHTSA), Hyundai is recalling 120,000 SUVs, and Kia is recalling 505,652 vehicles. The vehicles suffer from serious problems.